...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Long-term Effects of Pancreas Transplantation on Diabetic Retinopathy and Incidence and Predictive Risk Factors for Early Worsening
【24h】

Long-term Effects of Pancreas Transplantation on Diabetic Retinopathy and Incidence and Predictive Risk Factors for Early Worsening

机译:胰腺移植对早期恶化的糖尿病视网膜病变和预测危险因素的长期影响

获取原文
获取原文并翻译 | 示例

摘要

Background. Limited data are available regarding the long-term effects of pancreas transplantation on the progression of diabetic retinopathy (DR) and the incidence and associated risk factors for early worsening of DR. Methods. Patients who underwent successful pancreas transplantation between January 2007 and October 2015 and were followed for 1 year or longer were consecutively enrolled. Variables regarding demographic, systemic, metabolic, and surgical factors were reviewed for each patient. DR progression was defined as (i) development or aggravation ofmacular edema requiring intravitreal anti-VEGF injections and/or (ii) progression of DR severity requiring panretinal photocoagulation (PRP) and/or pars planar vitrectomy (PPV). Early worsening was defined as progression within 1 year of posttransplant. Results. Three hundred three eyes of 153 patients were included in the analysis. At the pretransplant ocular evaluation, 221 eyes (72.9%) showed advanced DR with history of PRP and/or PPV. During a mean follow-up period of 4.2 years, 62 eyes (20.5%) experienced DR progression, and early worsening was noted in 57 eyes (18.8%). DR with recent PRP within pretransplant 1 year and pancreas transplant alone were significant risk factors for early worsening. Conclusions. In 4 of 5 patients who received pancreas transplant, the degree of DR remained stable over time after transplantation. Meanwhile, early worsening of DR could occur in patients at risk, particularly within the first posttransplant year. We suggest that physicians should have a high index of suspicion and carefully monitor for early worsening of DR and timely manage possible ocular deterioration.
机译:背景。有限的数据可用于胰腺移植对糖尿病视网膜病变(DR)进展的长期影响以及早期恶化博士的发病率和相关危险因素。方法。在2007年1月至2015年10月期间成功进行了胰腺移植的患者,连续入学1年或更长时间。对每个患者审查了关于人口统计学,系统性,代谢和外科因素的变量。 DR进展被定义为(i)对需要玻璃体内抗VEGF注射的术治疗和/或(II)DR严重程度的进展的开发或加重,需要PANRetinal光凝(PRP)和/或平面玻璃体切除术(PPV)。早期恶化被定义为后翻盖的1年内的进展。结果。分析中包含153名患者的三百只眼睛。在预体形眼镜评估中,221只眼(72.9%)显示出PRP和/或PPV历史的先进博士。在4.2岁的平均随访期间,62只眼睛(20.5%)经历了博士进展,并在57只眼里注意到早期恶化(18.8%)。 Pretransplant中最近的PRP博士1年和单独的胰腺移植是早期恶化的显着风险因素。结论。在5名接受胰腺移植的患者中,移植后DR随时间保持稳定。与此同时,博士的早期恶化可能在风险的患者中发生,特别是在第一个后翻盖年内。我们建议医生应具有高度怀疑指标,并仔细监测博士的早期恶化,及时管理可能的眼睛恶化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号